Product Information
NIKKI 3 MG-0.02 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1895 per EA under NDC 68180088673. Its NADAC has been published 334 times since Feb 5, 2020.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180088673
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA201661On Market Since
11/30/2019
Price Statistics
The NADAC for NIKKI 3 MG-0.02 MG TABLET has been published 334 times since Feb 5, 2020, and over the history we have for it it has declined 55.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1895 per EA |
|---|---|
| All-time high | $0.4650 (Sep 16, 2020) |
| All-time low | $0.1278 (Nov 20, 2024) |
| 52-week high | $0.1895 |
| 52-week low | $0.1538 |
| Median price | $0.2757 |
| Average price | $0.2812 |
| Largest weekly change | -32.1% (Nov 20, 2024) |
| Weeks tracked | 334 |
| Tracking since | Feb 5, 2020 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NIKKI 3 MG-0.02 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NIKKI 3 MG-0.02 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1895 per EA (NDC 68180088673), effective Jun 24, 2026.
How has the price of NIKKI 3 MG-0.02 MG TABLET changed over time?
Over the history we have for it, the NADAC for NIKKI 3 MG-0.02 MG TABLET has declined 55.9%. It has been tracked across 334 weekly CMS publications since Feb 5, 2020.
What are the highest and lowest recorded NADAC prices for NIKKI 3 MG-0.02 MG TABLET?
Since Feb 5, 2020, the NADAC for NIKKI 3 MG-0.02 MG TABLET has ranged from a low of $0.1278 (Nov 20, 2024) to a high of $0.4650 (Sep 16, 2020), with a median of $0.2757 per EA.
Are there cheaper alternatives to NIKKI 3 MG-0.02 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DROSPIRENONE-EE 3-0.03 MG TAB, is $0.1538 per EA — about 19% below NIKKI 3 MG-0.02 MG TABLET.
Who manufactures NIKKI 3 MG-0.02 MG TABLET?
NIKKI 3 MG-0.02 MG TABLET (NDC 68180088673) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification